Skip to contentK
Kyntra Bio, Inc.
K
KYNBKyntra Bio, Inc. Q1 2018 · 10-Q
Revenue$31.93M$31.93M+8.4% vs Q1 2017 Net Income-$41.40M-$41.40MN/M vs Q1 2017 EPS Diluted-$0.50-$0.50N/M vs Q1 2017 Operating Income-$40,599,000N/M Operating Cash Flow
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Kyntra Bio, Inc. · CIK 921299 · Engraved from SEC EDGAR
Free Cash Flowderived-$33,800,000N/M Margins · derivedOperating margin-127.2%−29.3 pt vs Q1 2017
Net margin-129.7%−25.7 pt vs Q1 2017
ended Mar 31, 2018 · filed May 9, 2018 · 39 d after period end